Ocular Therapeutix OCUL Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's total costs & expenses?
- Ocular Therapeutix (OCUL) reported total costs & expenses of $104.13M in Q1 2026.
- How has Ocular Therapeutix's total costs & expenses changed year-over-year?
- Ocular Therapeutix's total costs & expenses increased by 39.5% year-over-year, from $74.62M to $104.13M.
- What is the long-term trend for Ocular Therapeutix's total costs & expenses?
- Over 4 years (2021 to 2025), Ocular Therapeutix's total costs & expenses has grown at a 27.6% compound annual growth rate (CAGR), from $121.56M to $321.97M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the total resources consumed to support business operations and pipeline development. Monitoring this figure is essential for assessing the company's overall cost structure and operational efficiency relative to revenue generation.